創辦人蔡長海先生專訪
Interview with Founder Mr. Chang-Hai Tsai
Interview with Founder Mr. Chang-Hai Tsai
深耕生醫衝刺三業務，打造大健康艦隊
An interview with founder Mr. Chang-Hai Tsai, who is deeply involved in the biomedical field, focusing on three key business areas to build a comprehensive healthcare fleet.
An interview with founder Mr. Chang-Hai Tsai, who is deeply involved in the biomedical field, focusing on three key business areas to build a comprehensive healthcare fleet.
長聖生技(6712)在創辦人蔡長海先生的領導下，持續創新研發新藥開發，勇於挑戰現今醫療瓶頸，與各衍生企業公司共同合作，朝大健康艦隊方向邁進。創辦人強調，台灣的生醫發展若能將政府資源、學術研究以及產業資金完善的結合，不僅很有機會培育出下一個諾貝爾獎得主，也有機會誕生國際級的生技大廠，讓台灣生技業站上國際舞台。
Under the leadership of its founder, Mr. Chang-Hai Tsai, Ever-Supreme (6712) continues to innovate in new drug development, boldly challenging current medical bottlenecks, and collaborating with various spin-off companies to move towards a comprehensive health industry. The founder emphasizes that if Taiwan's biomedical development can effectively combine government resources, academic research, and industry funding, it not only has a great chance to cultivate the next Nobel laureate but also the opportunity to create a world-class biotech giant, allowing Taiwan's biotech industry to stand on the international stage.
資料出處 Source of information：https://money.udn.com/money/story/5612/9217716